1. Market Research
  2. > Healthcare Market Trends
  3. > Acadia Healthcare Co. Company Profile - Business Description, Strategies, SWOT and Financial Analysis

“Acadia Healthcare Co. Company Profile” is a comprehensive report on Acadia Healthcare Co.. The report provides complete information on the operations, organization structure and financial information details of the company. Key strengths and weaknesses of the company on which the company can develop are included. In addition, potential opportunities and key threats in the short to medium term future are also identified. Key historical events and summary analysis of the company and strategy of the company are provided. Locations and subsidiary information and company statement are included in the report. The report also provides complete information on financial ratios and financial statement of Acadia Healthcare Co..

Table Of Contents

Acadia Healthcare Co. Company Profile - Business Description, Strategies, SWOT and Financial Analysis
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Key Highlights 5
2.1 Company Overview 5
2.2 Company Snapshot 6
2.3 Key Operational Strategies 6
3 Worldwide Operations 7
3.1 Global Locations 7
3.2 Subsidiaries and Affiliate Companies 9
4 SWOT Analysis 14
4.1 Strengths 14
4.2 Weaknesses 14
4.3 Opportunities 15
4.4 Threats 16
5 Latest Company Outlook Statement 17
6 Key Events and History 19
7 Business Operation Structure 20
8 Major Services Areas 23
8.1 Key Service Areas 23
9 Key Competitors 24
10 Key Employee Information 25
11 Financial Analysis 26
11.1 Income Statements 26
11.2 Balance Sheet 27
11.3 Cash Flow Statements 29
12 Contact Information 30
13 Latest News Landscape 31
13.1 Acadia Healthcare Announces the Acquisition of Six Inpatient Behavioral Health Facilities with 149 Beds in the United Kingdom - September, 2015 31
13.2 Acadia Healthcare Announces Completion of Belmont Behavioral Health Acquisition - July, 2015 31
13.3 Acadia Healthcare Announces Three Acquisitions, Which Include 17 Inpatient Behavioral Health Facilities with Approximately 500 Beds - June, 2015 32
13.4 Acadia Healthcare Acquires Quality Addiction Management - March, 2015 33
13.5 Acadia completes acquisition of CRC Health Group - February, 2015 34
14 Appendix 35
14.1 About Us 35
14.2 Sources and Methodology 35
14.3 Contact Information 36
14.4 Disclaimer 36

List Of Tables
Table 1: Acadia Healthcare - Top Level Information 6
Table 2: Acadia Healthcare - Key Operating Locations (II) 7
Table 3: Acadia Healthcare - Key Operating Locations (II) 8
Table 4: Acadia Healthcare - Key Subsidiaries (I) 9
Table 5: Acadia Healthcare - Key Subsidiaries (II) 10
Table 6: Acadia Healthcare - Key Subsidiaries (III) 11
Table 7: Acadia Healthcare - Key Subsidiaries (IV) 12
Table 8: Acadia Healthcare - Key Subsidiaries (V) 13
Table 9: Acadia Healthcare- Key events 19
Table 10: Acadia Healthcare - Key Executive Officers Information 25
Table 11: Acadia Healthcare - Board of Directors Information 25
Table 12: Acadia Healthcare- Income Statement 2013-2014 26
Table 13: Acadia Healthcare- Balance Sheet 2013-2014 (I) 27
Table 14: Acadia Healthcare Inc- Balance Sheet 2013-2014 (II) 28
Table 15: Acadia Healthcare- Cash Flow Statements 2013-2014 29


List of Figures
Figure 1: Acadia Healthcare- Total Revenues by Facility/Service, 2014 21

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H2 2016

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Intercellular Adhesion Molecule 1 (Major Group Rhinovirus ...

Hepatitis A - Pipeline Review, H2 2016

Hepatitis A - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • October 2016
  • by Global Markets Direct

Hepatitis A - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis A – Pipeline Review, H2 2016, provides an overview of the ...

Irritable Bowel Syndrome - Pipeline Review, H2 2016

Irritable Bowel Syndrome - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Irritable Bowel Syndrome - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome – Pipeline Review, H2 2016, provides ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.